Seaport Therapeutics
SPTX
17.93
+0.56
+3.22%
Seaport Therapeutics
US · SPTX
#3277 by market cap
Listed 2026
17.93
+0.56
+3.22%
Live - 5344 symbols - heartbeat 164s ago
· 2026-10-07 20:02
After-hours
17.93
0.00%
- Market cap
- 959.80M
- P/E (TTM)i
- -7.13
- P/Bi
- 2.27
- EPSi
- -1.41
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on SPTX?
Anonymous reader poll. Unscientific, not investment advice.
About Seaport Therapeutics
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.
- CEO
- Ms. Daphne Zohar
- Employees
- 58
- Headquarters
- Boston, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- seaporttx.com
Company profile
- Exchange
- US
- Symbol
- SPTX
- Market-cap rank
- #3277
- Listing date
- 2026-05-01
- Market cap
- 959.80M
- Float cap
- 253.89M
- Shares out
- 53.53M
- Float shares
- 14.16M
Sectors & themes
Biotechnology
IPOs
Quote time 2026-10-07 20:02:48 · For reference only, not investment advice and not tailored to your situation.